Phathom Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 452
- Market Cap
- $1B
- Website
- http://www.phathompharma.com
- Introduction
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Phathom Pharmaceuticals, Inc.
- Target Recruit Count
- 1046
- Registration Number
- NCT04167670
- Locations
- 🇺🇸
Carolina Research, Greenville, North Carolina, United States
🇺🇸Synexus Clinical Research US, Inc. - Anderson, Anderson, South Carolina, United States
🇺🇸Anaheim Clinical Trials LLC, Anaheim, California, United States
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
- First Posted Date
- 2019-10-14
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Phathom Pharmaceuticals, Inc.
- Target Recruit Count
- 1027
- Registration Number
- NCT04124926
- Locations
- 🇺🇸
Carolina Research, Greenville, North Carolina, United States
🇺🇸Central Sooner Research, Norman, Oklahoma, United States
🇺🇸Biopharma Informatic, LLC, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath